Literature DB >> 6107261

Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.

M J Daly, J M Humphray, R Stables.   

Abstract

The new H2-receptor antagonist, ranitidine, has been compared with cimetidine and metiamide as an inhibitor of gastric acid secretion in the dog. All three compounds were effective both intravenously or by mouth in inhibiting secretion induced by histamine, pentagastrin, or bethanechol. This inhibition was mainly attributable to a reduction in the volume of secretion, although there was also a significant reduction in the concentration of acid secreted. Metiamide was slightly less active than cimetidine, but ranitidine was four to nine times more potent than cimetidine, depending on the secretagogue used. The antisecretory activity of ranitidine does not result from a limitation in blood flow to the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107261      PMCID: PMC1419083          DOI: 10.1136/gut.21.5.408

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Clinical experience with metiamide.

Authors:  S J Haggie; C G Clark; J W Black; J H Wyllie
Journal:  Fed Proc       Date:  1976-06

2.  Some chemical aspects of histamine H2-receptor antagonists.

Authors:  C R Ganellin; G J Durant; J C Emmett
Journal:  Fed Proc       Date:  1976-06

3.  Safety and efficacy of cimetidine treatment.

Authors:  P C Sharpe
Journal:  Scott Med J       Date:  1977-10       Impact factor: 0.729

4.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

5.  Letter: Neutropenia associated with metiamide.

Authors:  J A Forrest; D J Shearman; R Spence; L R Celestin
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

6.  Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors.

Authors:  M I Grossman; S J Konturek
Journal:  Gastroenterology       Date:  1974-04       Impact factor: 22.682

7.  Actions of metiamide, an H2-histamine receptor antagonist, on gastric H+ and pepsin secretion in dogs.

Authors:  R Gibson; B I Hirschowitz; G Hutchison
Journal:  Gastroenterology       Date:  1974-07       Impact factor: 22.682

8.  Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.

Authors:  R M Henn; J I Isenberg; V Maxwell; R A Sturdevant
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

9.  The measurement of dog gastric mucosal blood flow by radioactive aniline clearance compared with amidopyrine clearance.

Authors:  B P Curwain; P Holton
Journal:  J Physiol       Date:  1973-02       Impact factor: 5.182

10.  The effect of (-)-isoprenaline and (+/-)-salbutamol on pepsinogen and acid secretion in the dog.

Authors:  M J Daly; R Stables
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

View more
  17 in total

1.  Dimethyl sulfoxide inhibits histamine release induced by various chemicals.

Authors:  L Candussio; F B Klugmann; G Decorti; S Bevilacqua; L Baldini
Journal:  Agents Actions       Date:  1987-02

2.  A long lasting gastrin response to apomorphine revealed by inhibitors of gastric acid secretion.

Authors:  M Goiny; K Brodin; C E Elwin; K Uvnäs-Moberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

3.  Effects of H2-receptor antagonists and anticholinoceptor drugs on gastric and salivary secretion induced by bethanechol in the anaesthetized dog.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

Review 4.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

5.  Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.

Authors:  R P Walt; I F Trotman; R Frost; P L Golding; T H Shepherd; J Rawlings; R H Hunt; D Colin-Jones; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

6.  Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

7.  The effect of ranitidine on gastric acid secretory response curves to histamine, pentagastrin or bethanechol in the dog with a Heidenhain pouch.

Authors:  M J Daly; J M Humphray; K T Bunce; R Stables
Journal:  Agents Actions       Date:  1981-04

Review 8.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

9.  The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbits.

Authors:  N L Harris; D E Brenner; L B Anthony; J C Collins; S Halter; K R Hande
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  The influence of the H-2 receptor antagonist ranitidine on cadaver kidney allograft function.

Authors:  T Orłowski; M Smogorzewski
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.